Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.75.10ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.75.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.10NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.75.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.75.10ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
B.1.36.21ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.36.21ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.36.21ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.36.21ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.36.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.21NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.36.21NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36.21ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.1.23ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.1.23ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.1.23ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.1.23ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.23NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.1.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.1.23ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.1.134ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.1.134ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.1.134ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.134ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.134NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.134NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.134ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AY.39.1.3 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
AY.39.1.3 (Delta)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
AY.39.1.3 (Delta)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.39.1.3 (Delta)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AY.39.1.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.39.1.3 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.39.1.3 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.39.1.3 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BN.1.3.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BN.1.3.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BN.1.3.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BN.1.3.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BN.1.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BN.1.3.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BN.1.3.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
C.38ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
C.38ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
C.38ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
C.38ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
C.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used